Upcoming Events

Discuss regulatory intelligence platforms’ critical role in the practice of regulatory science, allowing regulatory professionals to work more efficiently without compromising scientific rigor or judgment.

Explore the unseen risks at the intersection of Medical Information and Pharmacovigilance.

The upcoming 4th Edition of the IEC 60601 1 standard represents a significant evolution in the regulatory expectations for medical electrical equipment and medical electrical systems. This presentation will highlight the major conceptual and structural changes being introduced, with a focus on how these updates may impact design, documentation, and compliance activities for manufacturers and system integrators.

Utah RAPS Chapter St. George Event at Utah Tech

Learn from faculty at one of the world’s most prestigious business schools in an environment dedicated to preparing regulatory leaders.

Workshop virtual explora aplicações, oportunidades e desafios da inteligência artificial em Assuntos Regulatórios e tomada de decisão

RAPS Euro Convergence is the most comprehensive regulatory affairs conference in Europe, focusing on the latest topics and developments in healthcare products in Europe and beyond!

Learn how governed AI and Agile workflows help regulatory teams scale plain language summaries for CTIS, reduce manual rework, and support clearer, more consistent outputs—featuring a live AgileWriter.ai® demo.

RAPS Concurrent Workshop The Deployment of Practical, Compliant, and Real-World AI. AI is already being used inside regulated companies — the question is whether it’s being used safely and securely, and in a way that holds up under regulatory scrutiny. Additionally join us for the latest Notified Body perspective on EU MDR/IVDR & UKCA: What’s Changing and What It Means for You. EU MDR and IVDR implementation has proven more complex and burdensome than anticipated — and significant reforms are now being proposed to address these challenges.

This summit will explore what various regulatory-focused career paths entail and how regulatory experts help bring safe and efficacious products to market.

This session highlights how early development choices influence submission outcomes and teaches participants to anticipate key requirements and align plans with Health Canada expectations.

The MedTech Forum is the largest health and medical technology industry conference in Europe and a key event since 2007. Join industry leaders, leading innovators and investors to discuss the future opportunities in the medical technology sector.

Overview of chemistry, manufacturing and control (CMC) regulatory requirements and best practices associated with biologics. Emphasis on requirements in US, Europe, and other regions.

Manage EU MDR & 510(k) simultaneously without duplicating effort. Best-practice frameworks and practical guidance.

Learn how PRRCs are functioning at organizations small and large, internal or outsourced, manufacturer or authorized representative, and working with medical devices or IVDs.

Learn to become a regulatory strategic business partner when developing and reviewing advertising, promotional and labeling materials, with a focus on discernment between on-label, extra-label, and off-label claims.

Join us for a networking and recruitment series across multiple in-person events. Meet regulatory professionals, connect with chapter leaders, and learn about ambassador and leadership roles.

Whether you are new to medical devices or looking to strengthen your expertise, this intensive 16-hour course, delivered across four half days, has everything you need to confidently implement ISO 14971.

The RAPS NC Local Networking Group is pleased to present a panel discussion bringing together industry leaders and academic faculty to examine the current landscape of clinical research and regulatory affairs education in North Carolina and beyond. Panelists will share perspectives on the academic curricula that best prepare students and early-career professionals for meaningful, sustainable careers in clinical research and regulatory affairs. The conversation will explore where current programs excel, where critical gaps remain, and what new curricular offerings the profession needs to develop in response to an evolving regulatory and research environment. Panelists will also address professional development and training priorities for faculty and clinical research staff who are committed to advancing program quality and workforce readiness. This event is designed for clinical research professionals, regulatory affairs practitioners, academic faculty, students, and anyone with an interest in shaping the educational infrastructure that supports these fields. Attendees can expect candid dialogue, actionable insights, and an opportunity to connect with educators and industry leaders who are actively invested in growing the profession.

A focused exploration of ISO 10993-1:2025 revision that equips teams to align documentation and manage rising from 2018 revision when remain globally compliant with FDA guidance.

This interactive discussion will highlight the critical success factors in biologics development and launch programs, offering practical insights across the product life cycle, including understanding regulatory requirements early, risk management and contingency planning, integrated cross-functional collaboration, clinical development and data generation, manufacturing & supply chain considerations, regulatory agency interactions etc.

This educational webinar explores the evolving regulatory landscape governing the pharmaceutical and biotech industries, with a particular focus on the critical role of legal professionals in navigating compliance.

Charting your next regulatory career move? Join us in person to explore RAPS newest certification, hear from professionals across career stages, and leave with clarity on where your path is headed.

This is a RAPS-SF Executives event exclusive for VP and above. This facilitated roundtable discussion event brings together industry leaders to explore how organizations are navigating two critical challenges: implementing AI responsibly and making disciplined portfolio investment decisions.